EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism of Astragalus membranaceus (Huangqi, HQ ) for treatment of heart failure based on network pharmacology and molecular docking

Qiuxiang Chen, Juan Wang, Lihua Sun, Bayinsilema Ba, Difei Shen iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Qiuxiang Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Hubei Key Laboratory of Cardiol…. Hauptthemen laut MEDLINE: Astragalus propinquus, Heart Failure, Molecular Docking Simulation, Myocytes, Cardiac. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure is a leading cause of death in the elderly. Traditional Chinese medicine, a verified alternative therapeutic regimen, has been used to treat heart failure, which is less expensive and has fewer adverse effects. In this study, a total of 15 active ingredients of Astragalus membranaceus (Huangqi, HQ) were obtained; among them, Isorhamnetin, Quercetin, Calycosin, Formononetin, and Kaempferol were found to be linked to heart failure. Ang II significantly enlarged the cell size of cardiomyocytes, which could be partially reduced by Quercetin, Isorhamnetin, Calycosin, Kaempferol, or Formononetin. Ang II significantly up‐regulated ANP, BNP, β‐MHC, and CTGF expressions, whereas Quercetin, Isorhamnetin, Calycosin, Kaempferol or Formononetin treatment partially downregulated ANP, BNP, β‐MHC and CTGF expressions. Five active ingredients of HQ attenuated inflammation in Ang II‐induced cardiomyocytes by inhibiting the levels of TNF‐α, IL‐1β, IL‐18 and IL‐6. Molecular docking shows Isorhamnetin, Quercetin, Calycosin, Formononetin and Kaempferol can bind with its target protein ESR1 in a good bond by intermolecular force. Quercetin, Calycosin, Kaempferol or Formononetin treatment promoted the expression levels of ESR1 and phosphorylated ESR1 in Ang II‐stimulated cardiomyocytes; however, Isorhamnetin treatment had no effect on ESR1 and phosphorylated ESR1 expression levels. In conclusion, our results comprehensively illustrated the bioactives, potential targets, and molecular mechanism of HQ against heart failure. Isorhamnetin, Quercetin, Calycosin, Formononetin and Kaempferol might be the primary active ingredients of HQ, dominating its cardioprotective effects against heart failure through regulating ESR1 expression, which provided a basis for the clinical application of HQ to regulate cardiac hypertrophy and heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Astragalus propinquusHeart FailureMolecular Docking SimulationMyocytes, CardiacDrugs, Chinese HerbalNetwork PharmacologyAnimalsQuercetinAngiotensin IIKaempferolsRatsHumansIsoflavones

Stichwörter der Autor:innen

Astragalus membranaceus (Huangqi, HQ)heart failuremolecular dockingnetwork pharmacologytraditional Chinese medicine (TCM)

Substanzen

Drugs, Chinese HerbalHuang QiQuercetinAngiotensin IIKaempferolskaempferol7,3'-dihydroxy-4'-methoxyisoflavoneIsoflavones

Autor:innen und Institutionen

  • Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, China.
  • Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Cardiology, The Fifth Affiliated Hospital of Xinjiang medical University, Urumchi, China.

ORCID-Profile: Difei Shen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, Q., Wang, J., Sun, L., Ba, B., & Shen, D. (2024). Mechanism of Astragalus membranaceus (Huangqi, HQ ) for treatment of heart failure based on network pharmacology and molecular docking. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18331

Vancouver

Chen Q, Wang J, Sun L, Ba B, Shen D. Mechanism of Astragalus membranaceus (Huangqi, HQ ) for treatment of heart failure based on network pharmacology and molecular docking. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18331

BibTeX
@article{Chen2024,
  author = {Chen, Qiuxiang and Wang, Juan and Sun, Lihua and Ba, Bayinsilema and Shen, Difei},
  title = {Mechanism of Astragalus membranaceus (Huangqi, HQ ) for treatment of heart failure based on network pharmacology and molecular docking},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18331}
}
Kostenlos starten →